Impact of SARS-CoV-2 vaccine and infection history on antiviral immunity post breakthrough infection

Published: 12 April 2024| Version 1 | DOI: 10.17632/8tpxx5cxdg.1
Contributor:
Carla Saade

Description

Clinical and demographical data as well as serological and cellular humoral data obtained for all patients included in our study.

Files

Categories

Immunology, Humoral Immune Response, COVID-19 Vaccine

Licence